Susceptibility to tetanus and missed vaccination opportunities in Portuguese women

被引:6
|
作者
Gonçalves, G
Santos, MA
Cutts, FT
Barros, H
机构
[1] Fac Med Porto, Serv Higiene & Epidemiol, P-4200 Oporto, Portugal
[2] Inst Nacl Saude Dr Ricardo Jorge, Delegacao Porto, P-4000 Oporto, Portugal
[3] Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England
关键词
tetanus; vaccination; pregnancy;
D O I
10.1016/S0264-410X(98)00481-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Maternal and cord sera (96 pairs) were tested to measure antitetanus toxin IgG (ATT IgG) levels, using a commercial enzyme immunoassay. One mother had no detectable antitetanus antibody and four more had levels below those considered to be reliably protective (<160 mIU/ml). All five had been eligible for vaccination during pregnancy according to Portuguese guidelines, although one had received seven lifetime doses of TT. In maternal and cord sera, ATT IgG levels among those not vaccinated during the current pregnancy were significantly lower than among vaccinees (p < 0.0001), but there was no difference between those vaccinated once or twice during pregnancy. Among those not vaccinated during pregnancy, levels of ATT IgG decreased with time since last dose of vaccine (P = 0.0001). The total number of doses of vaccine was not significantly associated after controlling for time since last dose. Missed immunization opportunities occurred among half the women studied. Efforts to sustain protection against tetanus must be intensified. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1820 / 1825
页数:6
相关论文
共 50 条
  • [31] Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy
    Strassberg, Emmie R.
    Power, Michael
    Schulkin, Jay
    Stark, Lauren M.
    Mackeen, A. Dhanya
    Murtough, Katie L.
    Paglia, Michael J.
    VACCINE, 2018, 36 (30) : 4548 - 4554
  • [32] Increasing Frequency of Antenatal Care Visits May Improve Tetanus Toxoid Vaccination Coverage in Pregnant Women in Pakistan
    Iqbal, Sehar
    Ali, Inayat
    Ekmekcioglu, Cem
    Kundi, Michael
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (07) : 1529 - 1532
  • [33] Getting focused: missed opportunities for smoking interventions for pregnant women receiving Medicaid
    Petersen, R
    Clark, KA
    Hartmann, KE
    Melvin, CL
    PREVENTIVE MEDICINE, 2005, 40 (02) : 209 - 215
  • [34] Intranasal booster vaccination against diphtheria and tetanus in man
    Aggerbeck, H
    Gizurarson, S
    Wantzin, J
    Heron, I
    VACCINE, 1997, 15 (03) : 307 - 316
  • [35] Flaccid tetraplegia following anti-tetanus vaccination
    Perriol, MP
    Devos, D
    Hurtevent, JF
    Gautier, S
    Caron, J
    Destée, A
    REVUE NEUROLOGIQUE, 2004, 160 (10) : 942 - 944
  • [36] Cellular and humoral responses to tetanus vaccination in gabonese children
    van Riet, E.
    Retra, K.
    Adegnika, A. A.
    Jol-van der Zijde, C. M.
    Uh, H. -W.
    Lell, B.
    Issifou, S.
    Kremsner, P. G.
    Yazdanbakhsh, M.
    van Tol, M. J. D.
    Hartgers, F. C.
    VACCINE, 2008, 26 (29-30) : 3690 - 3695
  • [37] Vaccines for women to prevent neonatal tetanus
    Demicheli, Vittorio
    Barale, Antonella
    Rivetti, Alessandro
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05):
  • [38] Exploring Spatial Variation of Women's Tetanus Vaccination in Ethiopia: Spatial Analysis of Ethiopian Demographic and Health Survey 2016
    Belay, Alebachew Taye
    Mulugeta, Solomon Sisay
    Agegn, Setegn Bayabil
    Erega, Besfat Berihun
    SAGE OPEN, 2024, 14 (01):
  • [39] Tetanus vaccination in pregnant women: a systematic review and meta-analysis of the global literature
    Faria, A. P., V
    da Silva, T. P. R.
    Duarte, C. K.
    Mendes, L. L.
    Santos, F. B. O.
    Matozinhos, F. P.
    PUBLIC HEALTH, 2021, 196 : 43 - 51
  • [40] Missed opportunities for vaccination at point of care and their impact on coverage and urban-rural coverage inequity in the Gambia
    Sowe, Alieu
    Namatovu, Fredinah
    Cham, Bai
    Gustafsson, Per E.
    VACCINE, 2023, 41 (52) : 7647 - 7654